Maderer, A. et al. 2021. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. Acta Oncologica. 60, 11 (Nov. 2021), 1543–1547. DOI:https://doi.org/10.1080/0284186X.2021.1959057.